- Home
- NERV vs GLBS Comparison
NERV vs GLBS Comparison
Compare NERV & GLBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NERV | GLBS |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2M | 35.0M |
| IPO Year | 2014 | 2007 |
Fundamental Metrics
Financial Performance| Metric | NERV | GLBS |
|---|---|---|
| Price | $3.97 | $1.76 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $4.00 | $3.00 |
| AVG Volume (30 Days) | 40.4K | ★ 363.8K |
| Earning Date | 11-05-2025 | 11-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $39,444,000.00 |
| Revenue This Year | N/A | $24.03 |
| Revenue Next Year | N/A | $13.92 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.49 |
| 52 Week Low | $1.15 | $0.99 |
| 52 Week High | $12.46 | $1.99 |
Technical Indicators
Market Signals| Indicator | NERV | GLBS |
|---|---|---|
| Relative Strength Index (RSI) | 51.62 | 61.24 |
| Support Level | $3.70 | $1.41 |
| Resistance Level | $4.07 | $1.78 |
| Average True Range (ATR) | 0.29 | 0.13 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 62.37 | 50.00 |
Price Performance
Historical ComparisonAbout NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About GLBS Globus Maritime Limited
Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.